☆ 4.7 Review

Safety and Efficacy of Different Anticoagulant Doses for Patients with COVID-19 in the ICU: A Systematic Review and Meta-Analysis

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Anesthesiology

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study

R. Ferrandis et al.

Summary: This study examined the effect of LMWH dosage on critically ill COVID-19 patients. The results showed similar rates of bleeding and thrombotic events in both treatment and prophylaxis groups, with no influence of LMWH dosage on mortality.

REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19

Rosaria Sofia et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

添加到收藏夹

Letter Hematology

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis

Lorenzo Loffredo et al.

HAEMATOLOGICA (2022)

添加到收藏夹

Review Infectious Diseases

Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis

Hideto Yasuda et al.

Summary: This study used a network meta-analysis to examine the effects of different anticoagulant doses in patients with COVID-19. The results showed that both prophylactic and treatment doses were associated with a lower risk of short-term mortality compared to no treatment in patients with moderate COVID-19. However, there was no significant difference between the prophylactic and treatment dose groups. For patients with severe COVID-19, the absence of trials with a no-treatment group prevented a network meta-analysis, but pairwise comparison showed no significant difference between the prophylactic and treatment dose groups. Therefore, the treatment dose is preferred for both moderate and severe COVID-19 patients.

INFECTION (2022)

添加到收藏夹

Review Medicine, General & Internal

High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis

Emanuele Valeriani et al.

Summary: In hospitalized patients with COVID-19, high-dose thromboprophylaxis is more effective than low-dose for the prevention of venous thromboembolism (VTE) but increases the risk of major bleeding.

INTERNAL AND EMERGENCY MEDICINE (2022)

添加到收藏夹

Article Hematology

Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH

Alex C. Spyropoulos et al.

Summary: Despite the availability of high-quality trial data, there are still questions about the optimal patient selection, use of antithrombotics in different clinical settings, thromboprophylaxis in special patient populations, and management of acute thrombosis in hospitalized COVID-19 patients. The International Society on Thrombosis and Haemostasis (ISTH) formed a panel to develop recommendations on the use of anticoagulants and antiplatelet agents for COVID-19 patients. The panel agreed on 17 Good Practice Statements (GPS) to guide antithrombotic management in various clinical settings.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Review Medicine, General & Internal

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials

Konstantinos G. Kyriakoulis et al.

Summary: COVID-19 is strongly associated with increased risk for venous thromboembolism events. Pharmacologic thromboprophylaxis has shown significant benefits in reducing VTE events and mortality, especially in hospitalized patients. However, it is not routinely recommended for outpatient setting. Randomized controlled trials provide further support for optimal thromboprophylaxis strategies, but the evidence is mainly derived from observational studies with limitations.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Hematology

Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis

Filip Ionescu et al.

Summary: The study found that higher doses of anticoagulants were associated with lower mortality in hospitalized COVID-19 patients. Both therapeutic and prophylactic doses of anticoagulants were shown to reduce the risk of death, but patients receiving therapeutic anticoagulants were more prone to major bleeding.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Hematology

Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis

Rushad Patell et al.

Summary: The study found that hospitalized COVID-19 patients who received pharmacologic thromboprophylaxis had lower rates of thrombosis. Patients receiving intermediate-dose thromboprophylaxis or therapeutic anticoagulation had similar rates of thrombosis and bleeding compared to those who received standard-dose pharmacologic thromboprophylaxis.

THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Critical Care Medicine

Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

Julie Helms et al.

Summary: Using therapeutic anticoagulation in COVID-19 patients may decrease thrombotic complications without increasing bleeding risk, potentially improving survival rates.

ANNALS OF INTENSIVE CARE (2021)

添加到收藏夹

Review Critical Care Medicine

Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis

David Jimenez et al.

Summary: The pooled incidence of VTE and bleeding among hospitalized patients with COVID-19 was 17.0% and 7.8% respectively. Factors such as routine screening, critical illness, inclusion of distal DVT and subsegmental PE, and prospective studies were associated with higher rates of VTE. The incidence of bleeding events was sensitive to escalated doses of anticoagulants and the nature of data collection.

CHEST (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial

Alex C. Spyropoulos et al.

Summary: Therapeutic-dose low-molecular-weight heparin reduces major thromboembolism and death in high-risk inpatients with COVID-19, with no significant effect observed in critically ill patients.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial

Parham Sadeghipour et al.

Summary: This study compared the effect of intermediate-dose and standard prophylactic anticoagulation on a composite outcome among COVID-19 patients admitted to the ICU. The results showed no significant difference between the two groups in terms of thrombotic events, ECMO therapy, or mortality within 30 days. The study does not recommend routine use of intermediate-dose prophylactic anticoagulation in unselected ICU patients with COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Letter Infectious Diseases

Venous thrombosis prevention & COVID-19: Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients

Sebastian Voicu et al.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Review Hematology

Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis

Roberta Parisi et al.

Summary: A systematic review and meta-analysis on the association of anticoagulant use and in-hospital mortality in COVID-19 patients revealed a 50% reduction in mortality risk with anticoagulant use, especially in ICU patients. However, therapeutic anticoagulant regimens were associated with higher bleeding risks. Therefore, prophylactic dosages of anticoagulants may be preferred in noncritically ill patients.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)

添加到收藏夹

Review Peripheral Vascular Disease

Venous thromboembolism in COVID-19: A systematic review and meta-analysis

Anastasios Kollias et al.

Summary: Severe COVID-19 is associated with an increased risk of VTE, with higher prevalence in patients with higher D-dimer levels and a higher percentage of ICU patients. The pooled odds ratio for death in COVID-19 patients with VTE versus those without VTE was 2.1, indicating a higher mortality risk. Preventive anticoagulation therapy should be investigated further for individualized VTE risk assessment in COVID-19 patients.

VASCULAR MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Hematology

Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial

Usha S. Perepu et al.

Summary: In hospitalized adults with severe COVID-19, standard prophylactic dose and intermediate dose enoxaparin did not significantly differ in preventing death or thrombosis at 30 days. The occurrence of arterial or venous thrombosis was slightly higher than the rate of major bleeding.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Surgery

A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019

Yandong Liu et al.

Summary: The occurrence of VTE, DVT, and pulmonary embolism is substantial among hospitalized patients with COVID-19, especially those with severe COVID-19. Patients with severe COVID-19 and VTE have significantly greater mortality compared with similar patients without VTE. An increased D-dimer level might indicate the occurrence of VTE in patients with COVID-19.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2021)

添加到收藏夹

Letter Critical Care Medicine

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Qiurong Ruan et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann et al.

ANNALS OF INTERNAL MEDICINE (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan

Bin Ren et al.

CIRCULATION (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients

Sebastian Voicu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Hematology

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19

Alex C. Spyropoulos et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Songping Cui et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Editorial Material Hematology

The versatile heparin in COVID-19

Jecko Thachil

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

添加到收藏夹

Article Critical Care Medicine

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 CHEST Guideline and Expert Panel Report

Lisa K. Moores et al.

CHEST (2020)

添加到收藏夹

Editorial Material Hematology

Coagulation abnormalities and thrombosis in patients with COVID-19

Marcel Levi et al.

LANCET HAEMATOLOGY (2020)

添加到收藏夹

Article Hematology

Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis

Angelo Santoliquido et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis

Syed Shahzad Hasan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

添加到收藏夹

Review Medicine, General & Internal

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

Lucas C. Godoy et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Hematology

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Hematology

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Girish N. Nadkarni et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

添加到收藏夹

Article Hematology

Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study

Bjorn Stessel et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Critical Care Medicine

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients

K. Stattin et al.

JOURNAL OF CRITICAL CARE (2020)

添加到收藏夹

Article Hematology

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)

Anna Cristina Bertoldi Lemos et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Review Medicine, General & Internal

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Mahmoud B. Malas et al.

ECLINICALMEDICINE (2020)

添加到收藏夹

Article Psychiatry

How to perform a meta-analysis with R: a practical tutorial

Sara Balduzzi et al.

EVIDENCE-BASED MENTAL HEALTH (2019)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.